Accendra Health, Inc.

NYSE:ACH

Medical - Distribution

Healthcare
$0.71 +3.64%

+$0.12 today

Market cap
$54.22M
Beta
1.63
P/E (TTM)
-0.2
EPS (TTM)
-$14.11
52W Low $1.84High $9.55

Volume 1.41M

Average 0.83M

ACH Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Accendra Health, Inc.NYSE: ACH

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares declines year over year

Q1 FY2026 weighted avg shares of 76.7M shares fell 0.7% year over year, behind the -0.2% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +1.1% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -0.7% toward the trailing-twelve-month pace of -0.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
76.7M+0.0% QoQ
Last fiscal yearDec 2025
76.9M+0.2% YoY
LTMMar 2026
76.91M-0.2% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.7%——
1 year+0.2%——
3-year CAGR+1.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
76.9M USD
Year-over-year change
+0.2%
4-year CAGR
+1.4%

Weighted Avg Shares vs competitors

How ACH compares with its peers on the latest reported figures

  • ACH's LTM Mar 2026 weighted avg shares of 76.91M shares is the 7th highest of the 11 companies compared; the peer median is 88.19M shares.
  • Its year-over-year change of -0.2% is the lowest of 11, against a peer median of +11.1%.
  • Over three fiscal years its annual growth of +1.1% compares with a peer median of +12.5%.
ACH Competitors Peer median
Weighted Avg Shares for ACH and competitors
Company Period LTM YoY 3-year CAGR
CGCCanopy Growth CorporationLTM Mar 2026298.22M +210.7%+300.6%
ALLOAllogene Therapeutics, Inc.LTM Mar 2026225.47M +9.3%+15.5%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026124.17M +37.8%+23.4%
CABACabaletta Bio, Inc.LTM Mar 202694.61M +91.6%+51.6%
EDITEditas Medicine, Inc.LTM Mar 202690.28M +9.3%+8.9%
HITIHigh Tide Inc.LTM Apr 202686.1M +7.5%+9.4%
ACHAccendra Health, Inc.LTM Mar 202676.91M -0.2%+1.1%
SGHTSight Sciences, Inc.LTM Mar 202652.81M +4.4%+2.9%
BIOABioAge Labs, Inc.LTM Mar 202637.57M +7.3%+1.7%
CVRXCVRx, Inc.LTM Mar 202626.2M +12.8%+8.3%
OMOutset Medical, Inc.LTM Mar 202617.93M +423.3%+68.0%
Peer median (excluding ACH) 88.19M+11.1%+12.5%

Competitors are the stored peer set for ACH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue9.79B9.96B10.33B10.7B2.76B
Cost of Revenue8.27B8.13B8.21B8.48B1.56B
Gross Profit1.51B1.83B2.13B2.22B1.2B
Gross Margin15.5%18.3%20.6%20.7%43.5%
Research & Development12.1M0000
Selling, General & Admin1.08B1.55B1.81B1.91B1.05B
Operating Expenses1.14B1.68B2.02B2.43B1.05B
Depreciation & Amortization90.62M228.67M287.38M264.78M214.52M
EBITDA415.47M368.45M390.57M51.22M364.68M
EBITDA Margin4.2%3.7%3.8%0.5%13.2%
Operating Income368.47M142.91M104.51M(207.77M)150.16M
Operating Margin3.8%1.4%1.0%-1.9%5.4%
Interest Income00000
Interest Expense48.09M128.89M157.92M143.8M129.2M
Other Income / Expenses(91.72M)(132.02M)(159.23M)(149.59M)(252.11M)
Income Before Tax276.75M10.89M(54.73M)(357.36M)(101.95M)
Pre-Tax Margin2.8%0.1%-0.5%-3.3%-3.7%
Income Tax Expense55.17M(11.5M)(13.43M)5.33M729K
Net Income221.59M22.39M(41.3M)(362.69M)(1.1B)
Net Margin2.3%0.2%-0.4%-3.4%-39.8%
EPS (Basic)3.050.30(0.54)(4.73)(14.31)
EPS (Diluted)2.940.29(0.54)(4.73)(14.31)
Weighted Avg Shares72.74M74.5M75.79M76.74M76.9M
Weighted Avg Shares (Diluted)75.49M76.22M75.79M76.74M76.9M

Accendra Health, Inc.

NYSE:ACH

Intrinsic Alpha fair value

Locked

Current Price

$0.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.